NIS [non-interventional study] for patients using Symbicort [Budesonide/formoterol] turbuhaler for maintenance and reliever therapy in a single inhaler.

Trial Profile

NIS [non-interventional study] for patients using Symbicort [Budesonide/formoterol] turbuhaler for maintenance and reliever therapy in a single inhaler.

Completed
Phase of Trial: Phase III

Latest Information Update: 06 Oct 2008

At a glance

  • Drugs Budesonide/formoterol (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Sponsors AstraZeneca
  • Most Recent Events

    • 06 Oct 2008 Last checked against ClinicalTrials.gov record.
    • 24 Sep 2008 Actual end date (Sep 2008) added as reported by ClinicalTrials.gov.
    • 24 Sep 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top